Online Inquiry
RIP Antibody
SPA-09626
| Size | Price |
| 25 µg | Online Inquiry |
| 100 µg | Online Inquiry |
| More Options | Online Inquiry |
| Target Information | |
|---|---|
| Target Name | RIP |
| Gene Abbr. | RIPK1 |
| Gene ID | 8737 |
| Full Name | receptor interacting serine/threonine kinase 1 |
| Alias | AIEFL, IMD57, RIP, RIP-1, RIP1 |
| Introduction | The receptor-interacting protein (RIP) family of serine-threonine kinases (RIP, RIP2, RIP3, and RIP4) are important regulators of cellular stress that trigger pro-survival and inflammatory responses through the activation of NF-κB, as well as pro-apoptotic pathways. In addition to the kinase domain, RIP contains a death domain responsible for interaction with the death domain receptor Fas and recruitment to TNF-R1 through interaction with TRADD. RIP-deficient cells show a failure in TNF-mediated NF-κB activation, making the cells more sensitive to apoptosis. RIP also interacts with TNF-receptor-associated factors (TRAFs) and can recruit IKKs to the TNF-R1 signaling complex via interaction with NEMO, leading to IκB phosphorylation and degradation. Overexpression of RIP induces both NF-κB activation and apoptosis. Caspase-8-dependent cleavage of the RIP death domain can trigger the apoptotic activity of RIP. |
| Product Details | |
|---|---|
| Host | Mouse |
| Clonality | Monoclonal |
| Clone No. | 334640 |
| Isotype | IgG1 |
| Immunogen | E. coli-derived recombinant human RIPK1/RIP1. Met1-Asn671. Q13546. |
| Usage | |
|---|---|
| Application | WB, IF |
| Dilutions | Western Blot (0.5 µg/mL); Immunofluorescence (8-25 µg/mL) |
| MW(KDa) | 78-82 |
| Reactivity | Human, Mouse, Rat |
| Validation | Knockout Validated. |
| Specificity | Detects human, mouse and rat RIPK1/RIP1 in Western Blots. |
| Storage & Handling | |
|---|---|
| Storage Buffer | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Preservative | No Preservative |
| Storage Temp. | 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution. |
| Handling | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.